Your browser doesn't support javascript.
loading
Advanced Parkinson's disease: clinical characteristics and treatment. Part II.
Kulisevsky, J; Luquin, M R; Arbelo, J M; Burguera, J A; Carrillo, F; Castro, A; Chacón, J; García-Ruiz, P J; Lezcano, E; Mir, P; Martinez-Castrillo, J C; Martínez-Torres, I; Puente, V; Sesar, A; Valldeoriola-Serra, F; Yañez, R.
Affiliation
  • Kulisevsky J; Servicio de Neurologia, Hospital Sant Pau, Barcelona, España. Electronic address: JKulisevsky@santpau.cat.
Neurologia ; 28(9): 558-83, 2013.
Article in En, Es | MEDLINE | ID: mdl-23880230
ABSTRACT

INTRODUCTION:

Many patients who have had Parkinson's disease (PD) for several years will present severe motor fluctuations and dyskinesias which require more aggressive therapies. The different approaches which are now available include deep brain stimulation of the subthalamic nucleus or medial globus pallidus, subcutaneous infusion of apomorphine, and intestinal infusion of levodopa-carbidopa.

OBJECTIVE:

To define the indications and results for the 3 available therapies for advanced PD. DEVELOPMENT Exhaustive review of the literature concerning the indications and results of deep brain stimulation, subcutaneous apomorphine infusion and duodenal infusion of levodopa/carbidopa gel to treat patients with advanced Parkinson disease.

CONCLUSIONS:

Although numerous studies have confirmed the efficacy of the 3 different therapies in advanced PD, there are no comparative studies that would allow us to define the best candidate for each technique.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease Type of study: Etiology_studies Limits: Humans Language: En / Es Journal: Neurologia Journal subject: NEUROLOGIA Year: 2013 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease Type of study: Etiology_studies Limits: Humans Language: En / Es Journal: Neurologia Journal subject: NEUROLOGIA Year: 2013 Document type: Article